José M. Silva

5.0k total citations · 1 hit paper
55 papers, 3.8k citations indexed

About

José M. Silva is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, José M. Silva has authored 55 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in José M. Silva's work include Pharmacogenetics and Drug Metabolism (10 papers), Cancer Genomics and Diagnostics (9 papers) and Inflammatory mediators and NSAID effects (7 papers). José M. Silva is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Cancer Genomics and Diagnostics (9 papers) and Inflammatory mediators and NSAID effects (7 papers). José M. Silva collaborates with scholars based in Spain, United States and Canada. José M. Silva's co-authors include Gregory J. Hannon, Félix Bonilla, Javier Silva, Stephen J. Elledge, J.M. Jurado, Gemma Domínguez, Deborah A. Nicoll‐Griffith, Pilar España, Ravi Sachidanandam and Mariano Provencio and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

José M. Silva

53 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A resource for large-scale RNA-interference-based screens in mammals

2004 554 citations Patrick J. Paddison, José M. Silva et al. profile →

Peers

José M. Silva

ONCOL

GENET

PHARM

Moulay A. Alaoui‐Jamali Canada

Hannes Hentze Singapore

Benjamin Yat‐Ming Yung Taiwan

Germán Pihán United States

Pasquale Chieco Italy

Phyllis A. Svingen United States

Muthusamy Kunnimalaiyaan United States

Jianxin Gu China

Takeshi Tomonaga Japan

Davide Treré Italy

Moulay A. Alaoui‐Jamali Canada

José M. Silva

3.1k ×1.2

792 ×1.0

1.3k ×1.8

ONCOL

338 ×0.7

GENET

108 ×0.3

PHARM

Citations per year, relative to José M. Silva José M. Silva (= 1×) peers Moulay A. Alaoui‐Jamali

Countries citing papers authored by José M. Silva

Since Specialization

Citations

This map shows the geographic impact of José M. Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José M. Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José M. Silva more than expected).

Fields of papers citing papers by José M. Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José M. Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José M. Silva. The network helps show where José M. Silva may publish in the future.

Co-authorship network of co-authors of José M. Silva

This figure shows the co-authorship network connecting the top 25 collaborators of José M. Silva. A scholar is included among the top collaborators of José M. Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José M. Silva. José M. Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plata, Mauricio, et al.. (2022). Performance of the artificial urinary sphincter implantation in men with urinary incontinence: Results from a contemporary long‐term real‐world nationwide analysis. Neurourology and Urodynamics. 41(7). 1573–1581. 8 indexed citations

Bardot, Evan, Víctor Julián Valdés, Jisheng Zhang, et al.. (2013). Polycomb subunits Ezh1 and Ezh2 regulate the Merkel cell differentiation program in skin stem cells. The EMBO Journal. 32(14). 1990–2000. 86 indexed citations

Ezhkova, Elena, Wen‐Hui Lien, Nicole Stokes, et al.. (2011). EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair. Genes & Development. 25(5). 485–498. 281 indexed citations

Silva, José M., Krista Marran, Joel S. Parker, et al.. (2008). Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening. Science. 319(5863). 617–620. 225 indexed citations

Lévesque, Jean-François, Stephen H. Day, Nathalie Chauret, et al.. (2007). Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: Impacts of glutathione trapping and glucuronide conjugation on covalent binding. Bioorganic & Medicinal Chemistry Letters. 17(11). 3038–3043. 20 indexed citations

Nicoll‐Griffith, Deborah A., Carmai Seto, Yves Aubin, et al.. (2006). In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Bioorganic & Medicinal Chemistry Letters. 17(2). 301–304. 14 indexed citations

Fonseca, Francisco Antônio Helfenstein, Álvaro J. Ruiz, Ernesto Germán Cardona-Muñóz, et al.. (2005). The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL‐C Value – an Evaluation of Rosuvastatin therapY compared with atorvastatin. Current Medical Research and Opinion. 21(8). 1307–1315. 28 indexed citations

Silva, José M., Mamie Z. Li, Ken C. N. Chang, et al.. (2005). Second-generation shRNA libraries covering the mouse and human genomes. Nature Genetics. 37(11). 1281–1288. 491 indexed citations

Silva, José M., et al.. (2004). RNA interference microarrays: High-throughput loss-of-function genetics in mammalian cells. Proceedings of the National Academy of Sciences. 101(17). 6548–6552. 122 indexed citations

10.

Caudy, Amy A., René F. Ketting, Scott M. Hammond, et al.. (2003). A micrococcal nuclease homologue in RNAi effector complexes. Nature. 425(6956). 411–414. 356 indexed citations

11.

Domínguez, Gemma, Javier Silva, J.M. Jurado, et al.. (2003). Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 530(1-2). 9–17. 71 indexed citations

12.

García, José Manuel Pacheco, Rufo Rodríguez, Javier Silva, et al.. (2003). Intratumoral Heterogeneity in Microsatellite Alterations in BRCA1 and PTEN Regions in Sporadic Colorectal Cancer. Annals of Surgical Oncology. 10(8). 876–881. 10 indexed citations

13.

Silva, José M., Gemma Domínguez, J.M. Jurado, et al.. (2003). Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. The Journal of Pathology. 199(3). 289–297. 90 indexed citations

14.

Leblanc, Yves, Patrick Roy, Zhaoyin Wang, et al.. (2002). Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile. Bioorganic & Medicinal Chemistry Letters. 12(22). 3317–3320. 13 indexed citations

15.

Chauret, Nathalie, James A. Yergey, Christine Brideau, et al.. (2001). In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). Bioorganic & Medicinal Chemistry Letters. 11(8). 1059–1062. 36 indexed citations

16.

Silva, Javier, Gemma Domínguez, José M. Silva, et al.. (2001). Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene. 20(33). 4586–4590. 44 indexed citations

17.

Domínguez, Gemma, Javier Silva, José M. Silva, et al.. (2001). Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status. Genes Chromosomes and Cancer. 31(2). 99–106. 10 indexed citations

18.

Domínguez, Gemma, Javier Silva, José M. Silva, et al.. (2000). Clinicopathological characteristics of breast carcinomas with allelic loss in the p73. Breast Cancer Research and Treatment. 63(1). 17–22. 7 indexed citations

19.

Silva, José M., Stephen H. Day, & Deborah A. Nicoll‐Griffith. (1999). Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. Chemico-Biological Interactions. 121(1). 49–63. 69 indexed citations

20.

Silva, José M., R Martinez Gonzalez, Mariano Provencio, et al.. (1999). Loss of heterozygosity in BRCA1 and BRCA2 markers and high‐grade malignancy in breast cancer. Breast Cancer Research and Treatment. 53(1). 9–17. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact